Cardiovascular Associates of the Southeast — Birmingham, Alabama

Cardiovascular Associates of the Southeast is a clinical research site located in Birmingham, Alabama, United States 35243.

Crixeo Clinical Trials Trust Score: 19/100 (FAILING). This profile has not yet been claimed by the site owner.

Cardiovascular Associates of the Southeast has participated in 13 clinical trials with 3 currently active.

Therapeutic areas: Diabetes Mellitus, Type 2, Peripheral Arterial Disease, Stroke, Acute.

Sponsors: Novo Nordisk A/S, Medtronic Cardiac Rhythm and Heart Failure, Viatris Innovation GmbH.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Birmingham

Browse all research sites in Alabama · View every site in Birmingham

Sponsor Feasibility Report

Trust Score: 19/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Cardiovascular Associates of the Southeast?

Cardiovascular Associates of the Southeast has a Crixeo Trust Score of 19/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Cardiovascular Associates of the Southeast conducted?

Cardiovascular Associates of the Southeast has 13 clinical trials on record, with 3 currently active. Their work covers Diabetes Mellitus, Type 2, Peripheral Arterial Disease, Stroke, Acute.

Is Cardiovascular Associates of the Southeast accredited by Crixeo Clinical Trials?

Cardiovascular Associates of the Southeast has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Cardiovascular Associates of the Southeast?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.